Immunocytochemical profile benign carcinomatous effusions practical approach difficult diagnosis great challenges cytodiagnosis effusions distinction reactive mesothelium/histiocytes cancer cells true patients undergone radiation and/or chemotherapy monoclonal antibodies MoAbs reliable diagnostic adjuvants authors cases standard cytologic criteria malignant benign equivocal panel available MoAbs cytokeratins vimentin EMA alpha-CEA lectin Ulex europaeus malignant cases reactivity EMA HMFG alpha-CEA Combinations EMA EMA alpha-CEA EMA alpha-CEA positivity malignant cases benign cases HMFG EMA case EMA results equivocal cases malignant benign cases Follow-up effusions months patients authors diagnosis combination EMA MoAbs malignant cells cases incidence false positive cases study panel EMA alpha-CEA MoAbs useful simple approach correct diagnosis questionable effusions potential pitfalls 